Efficacy and Mechanism Evaluation (EME)  



The EME Programme bridges the gap between preclinical studies and evidence of clinical efficacy. The aim is to secure the progress of new technologies and interventions through early clinical trials and onto larger, later clinical trials. The EME Programme supports excellent clinical science with an ultimate view to improving health or patient care.

The programme supports clinical trials and evaluative studies in patients which evaluate clinical efficacy of interventions where proof of concept in humans has already been achieved, add significantly to our understanding of biological or behavioural mechanisms and processes, or explore new scientific or clinical principles; and include the development or testing of new methodologies.

There are two workstreams, researcher-led and commissioned. Both workstreams fund large projects with clear stages and milestones. Proposals may include pilot and feasibility studies and late development of technologies. The programme welcomes collaborations with industry
and charities.

The EME Programme is a partnership between the Medical Research Council (MRC) and the NIHR. Researchers in England, Northern Ireland, Scotland and Wales are eligible to apply.

Calls/Competitions Researcher-led and commissioned calls
Application process Typically two stage
Alerts www.nets.nihr.ac.uk/sign-up
Contact info@eme.ac.uk
Website www.nets.nihr.ac.uk/programmes/eme

For a list of NIHR funding deadlines
take a look at our funding deadlines page.




Contact us   Connect with us Connect with us on Google+ Connect with us on YouTube
© 2017 RDS South West | Design by Russell Holloway